The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1b study of chemoimmunotherapy with pegylated liposomal doxorubicin and pembrolizumab in estrogen receptor-positive, endocrine-resistant breast cancer.
 
Alberto A. Gabizon
Research Funding - Merck Sharp & Dohme (Inst)
Patents, Royalties, Other Intellectual Property - liposomal drugs
 
Nathan Cherny
No Relationships to Disclose
 
Rut Isacson
No Relationships to Disclose
 
Areen Abu Remilah
No Relationships to Disclose
 
Alberto Gabizon
No Relationships to Disclose
 
Hilary Shmeeda
No Relationships to Disclose
 
Ora Rosengarten
No Relationships to Disclose